Post
Voyager doses first patient with anti-tau antibody in Alzheimer’s trial
Voyager Therapeutics has dosed the first patient in a Phase Ia single-ascending dose study of its investigational anti-tau antibody VY-TAU01 …
Bayer’s non-hormonal therapy reduces hot flashes in Phase III trials
Bayer’s non-hormonal therapy elinzanetant met primary and secondary endpoints in two pivotal Phase III trials by reducing the frequency and …
Elixir’s focal stress system to treat calcified lesions hits success in trial
Elixir Medical has reported positive data from the PINNACLE I clinical trial evaluating the safety and effectiveness of its catheter …
Parallel Bio launches Clinical Trial in a Dish to predict drug efficacy
US-based biotech company Parallel Bio has introduced 'Clinical Trial in a Dish' to enhance early-stage drug discovery. This innovative approach utilises …
Eli Lilly’s efsitora alfa shows promise in Phase III T2D trials
Eli Lilly has reported positive outcomes from the Phase III QWINT-2 and QWINT-4 clinical trials of insulin efsitora alfa (efsitora) …
AstraZeneca’s Phase III Covid-19 antibody trial meets primary endpoints
AstraZeneca has announced that the Phase III SUPERNOVA clinical trial of its sipavibart (formerly AZD3152) met the primary endpoints in …
Top ESG Consulting Firms for Clinical Research Companies
Top ESG consulting firms for clinical research companies: Introduction In the rapidly evolving world of clinical research, environmental, social and governance …
BMS reports four-year data from psoriasis treatment extension trial
Bristol Myers Squibb (BMS) has revealed four-year data from the POETYK PSO long-term extension (LTE) trial of Sotyktu in treating …
Top Clinical Research Organisations, Companies and Solutions
Top clinical research organisations, companies and solutions: Introduction In the intricate and complex world of medical advancements and pharmaceutical breakthroughs, the …
Ionis and Biogen discontinue experimental ALS drug after Phase I/II flop
Ionis and Biogen are halting the development of their experimental treatment for amyotrophic lateral sclerosis (ALS) after it failed to …
TB outbreak spurs public health emergency in California
On 2 May 2024, the city of Long Beach, California declared a local public health emergency due to an outbreak …
Uniquity Bio launches with $300m and an MSD Phase II asset to boot
Private investment firm Blackstone Life Sciences has pulled back the covers on the latest pharma company to hit the immunology …
Roche targets obesity market with early positive trial data
Roche is looking to share in the windfall from the sales in obesity therapies as it announces positive results from …
FDA report highlights need to improve diversity in clinical trials
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) is continuing a push to improve …
Vanda Pharmaceuticals reports positive data from motion sickness trial
Vanda Pharmaceuticals has reported positive outcomes from its second Phase III clinical trial of tradipitant, aimed at treating motion sickness. Dubbed …